21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Injection preparation and method for producing the same
#1502ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SKIN AND NAILS
#1503Ophthalmic composition and methods of use
#1504Lyophilized pharmaceutical compositions
#1505Long-acting polymeric delivery systems
#1506Rapid action insulin formulations and pharmaceutical delivery systems
#1507Herbal combinations for treating eczema
#1508Antimicrobial compositions comprising glyceryl nitrates
#1509ANTI-MICROBIAL COMPOSITION COMPRISING CANNABINOIDS
#1510COMPOSITIONS WITH REDUCED DIMER FORMATION
#1511Method for reducing critical micelle concentration, and surfactant composition
#1512Sublingual buprenorphine spray
#1513Cosmetic and Pharmaceutical Foam
#1514Formulations for aripiprazole delivery transdermally
#1515Drug formulations
#1516Cryoprotected, frozen recombinant cancer cells
#1517Compositions and methods for reducing intraocular pressure
#1518BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS AND METHODS OF USE
#1519Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum
#1520ALDITOL-FREE, STORAGE-STABLE THYROID HORMONE ACTIVE DRUG FORMULATIONS AND METHODS FOR THEIR PRODUCTION
#1521Transdermal compositions of ibuprofen and methods of use thereof
#1522USE OF RICE BRAN OIL DISTILLATE EXTRACT FOR PREVENTION AND MITIGATION OF THE EFFECTS OF RADIATION
#1523Dosage regimen of ferric trimaltol
#1524Excipients for stabilising viral particles, polypeptides or biological material
#1525Abuse-resistant drug formulations
#1526Composition comprising tetracyclic compound
#1527METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORM OF SOLUTIONS OR SUSPENSIONS
#1528METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#1529GLP-1 receptor stabilizers and modulators
#1530LIQUID STATIN FORMULATION
#1531Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#1532LIQUID FORMULATION OF FSH
#1533LIQUID FORMULATION OF FSH
#1534LIQUID FORMULATION OF FSH
#1535Method for preparing an anthelmintic composition, anthelmintic composition, veterinary treatment method and anthelmintic treatment method
#1536SELF-FOAMING COMPOSITIONS AND METHODS
#1537Formulations of bendamustine
#1538Formulations of bendamustine
#1539INJECTABLE ALBUMIN BASED VASCULAR OCCLUDER
#1540PHARMACEUTICAL COMPOSITION COMPRISING A POORLY WATER-SOLUBLE ACTIVE INGREDIENT, A SURFACTANT AND A WATER-SOLUBLE POLYMER
#1541TOPICAL FORMULATIONS, SYSTEMS, AND METHODS
#1542Transduction buffer
#1543Concentrated natamycin suspension formulations
#1544THERAPEUTIC OXIDATIVE FORMULATIONS AND METHODS OF USE THEREOF
#1545Nanoparticles and nanoparticle compositions
#154617alpha, 21-dihydroxypregnene esters as antiandrogenic agents
#1547Apixaban liquid formulations
#1548Antimicrobial compositions
#1549Variants of C-Type Natriuretic Peptide
#1550METHOD TO SOLUBILIZE CURCUMINOIDS IN WATER
#1551DERMAL DELIVERY COMPOSITIONS AND METHODS
#1552Stabilized pharmaceutical dosage forms comprising atrasentan
#1553INHALED AEROSOLIZED IMMUNO-CHEMOTHERAPY FOR THE TREATEMENT OF MDR TB
#1554HFSH AQUEOUS FORMULATION
#1555Compositions for Dermatological Use
#1556Injection preparation and method for producing same
#1557Slow-release conjugates of SN-38
#1558BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#1559TOPICAL PIGMENTORY COMPOSITION
#1560Stabilised Solid Compositions of Factor VII Polypeptides
#1561TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#1562Diclofenac topical formulation
#156317-hydroxyprogesterone ester-containing oral compositions and related methods
#1564Compositions And Methods Of Treatment Of Inflammatory Skin Conditions Using Allantoin
#1565Pharmaceutical liquid composition of botulinum toxin with improved stability and method of use
#1566Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
#1567ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE
#1568Lipids and compositions for the delivery of therapeutics
#1569ADHESIVE PATCH
#1570Reaction platform and method for making pollen based materials in combination with beeswax and uses thereof
#1571Chlorogenic acid powder-injection and preparation method thereof
#1572MANAGEMENT OF OSTEOARTHRITIS USING POOLED ALLOGENEIC MESENCHYMAL STEM CELLS
#1573ANTIFUNGAL COMBINATION THERAPY OF TAVABOROLE AND CICLOPIROX
#1574Dermal compositions
#1575Liquid bendamustine formulation
#1576Surface-modified heavy metal nanoparticles, compositions and uses thereof
#1577Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
#1578Stable formulations for parenteral injection of small molecule drugs
#1579Topical composition and delivery system and its use
#1580Formulations of bendamustine
#1581Formulations of bendamustine
#1582Formulations of bendamustine
#1583Formulations of bendamustine
#1584Highly concentrated pharmaceutical formulations
#1585Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
#1586Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent
#1587Stabilized pemetrexed formulation
#1588Composition, method, and kit for alpha-1 proteinase inhibitor
#1589Sulfated oligohydroxycarboxylic acid esters, and use thereof
#1590Therapeutic foam
#1591Aqueous gel formulations containing immune response modifiers
#1592Stabilised Compositions of Factor VII Polypeptides
#1593Composition for the treatment of joint conditions
#1594Allantoin-Containing Skin Cream
#1595HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
#1596Lyophilized Preparation of Botulinum Toxin
#1597NK3 receptor antagonist compound (NK3RA) for use in a method for the treatment of polycystic ovary syndrome (PCOS)
#1598ENGINEERED MICROGELS
#1599Stable high strength pharmaceutical composition of levoleucovorin
#1600Lipids for therapeutic agent delivery formulations
#1601Fulvestrant formulations
#1602Pemetrexed Formulation
#1603Oral transmucosal pharmaceutical compositions including testosterone and a C-SERM
#1604Diclofenac topical formulation
#1605Treatment of pain with topical diclofenac
#1606Injectable controlled release composition comprising high viscosity liquid carrier
#1607Compositions with reduced dimer formation
#1608Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
#1609Anhydrous compositions
#1610Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection
#1611Methods and pharmaceutical compositions for the treatment of symptoms of anxiety and panic using beta adrenergic receptor antagonist and muscarinic receptor antagonist combinations
#1612Methods and pharmaceutical compositions for the treatment of symptoms of anxiety and panic using beta adrenergic receptor antagonist and muscarinic receptor antagonist combinations
#1613Analgesic compositions
#1614SOLID COMPOSITIONS COMPRISING A GLUCOKINASE ACTIVATOR AND METHODS OF MAKING AND USING THE SAME
#1615DRUG COMBINATIONS
#1616Nano / micro bubbles for drug delivery
#1617Pharmaceutical composition for preparing drug delivery nano/micro bubbles
#1618Low concentration antibody formulations
#1619Oral Drug Devices and Drug Formulations
#1620Formulations of bendamustine
#1621Solid dispersions of low-water solubility actives
#1622Compositions Containing Chondroitin Sulphate, Proteolytic Enzymes and Sulphydryl Compounds for Improving the Bioavailability of Chondroitin Sulphate
#1623Assembly of micelle aggregates of surfactant micelles and silver nanoparticles and use as antibacterial agent
#1624TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#1625PHARMACEUTICAL ADHESIVE COMPOSITIONS FOR TREATMENT OF EPISTAXIS AND METHODS OF USE THEREOF
#1626Composition and method for compounded therapy
#1627Composition and method for compounded therapy
#1628COMPOSITION AND METHOD FOR COMPOUNDED THERAPY
#1629TRANS-RESVERATROL OR TRANS-RESVERATROL DERIVATIVE COMPOSITION
#1630Stabilised Solid Compositions of Factor VII Polypeptides
#1631Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
#1632Antimicrobial compositions
#1633Compositions for internal and external use as an insecticide, ovicide, repellent and for wound healing
#1634Coloured disinfectant preparation based on bispyridiniumalkane
#1635Antifungal compositions for the treatment of skin and nails
#1636Compositions and methods for treating skin cancer associated diseases
#1637Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants
#1638PRODUCT AND METHOD FOR TREATMENT OF A BIOFILM, INCLUDING CONTROL OF SUBSTRATE COLONIZATION AND TREATMENT OF INFECTION
#1639Composition
#1640Treatment of pain with topical diclofenac
#164117-hydroxyprogesterone ester-containing oral compositions and related methods
#1642TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#1643Treatment of pain with topical diclofenac
#1644Diclofenac topical formulation
#1645Compositions of aluminum fluoride and methods of use thereof for the treatment and prevention of actinic keratosis and sun-induced damages
#1646ENHANCED NITRIC OXIDE DELIVERY AND USES THEREOF
#1647Stable pharmaceutical composition
#1648Methods and compositions for inactivating enveloped viruses
#1649Mixture of betamethasone and tranilast with a transdermal gel for scar treatment
#1650THERMOSENSITIVE INJECTABLE GLAUCOMA DRUG CARRIER GEL AND THE FABRICATING METHOD THEREOF
#1651Long-acting polymeric delivery systems
#1652Stabilized pemetrexed formulation
#1653Topical formulations for treating skin conditions
#1654Formulations of dimethyl trisulfide for use as a cyanide antidote
#1655Foamable formulation
#1656Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC region
#1657Solvent/polymer solutions as suspension vehicles
#1658COMPOSITIONS COMPRISING CHALCOGENIDES AND RELATED MATTERS
#1659TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS
#1660Co-micronization product comprising ulipristal acetate
#1661Stabilized compositions of proteins having a free thiol moiety
#1662DRUG DELIVERY COMPOSITION
#1663Biocompatible hydrogel treatments for retinal detachment
#1664Antimicrobial compositions and related methods
#1665Topical compositions and methods of treatment of anorectal disorders
#1666Microbial-relief composition
#1667Lipids and compositions for the delivery of therapeutics
#1668SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#1669Nanosuspension of a poorly soluble drug via microfluidization process
#1670PREPARATION OF GGA AND DERIVATIVES THEREOF AND THEIR CO-CRYSTALLIZATION WITH UREA OR THIOUREA
#1671OSMOTIC DELIVERY DEVICE COMPRISING AN INSULINOTROPIC PEPTIDE AND USES THEREOF
#1672Multicomponent degradable cationic polymers
#1673Formulations of bendamustine
#1674Liquid stable virus vaccines
#1675PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#1676Asymmetric ionizable cationic lipid for RNA delivery
#1677Ionizable cationic lipid for RNA delivery
#1678Pharmaceutical preparation comprising aminopyrazole derivative
#1679Diclofenac topical formulation
#1680Diclofenac topical formulation
#1681Diclofenac topical formulation
#1682Apixaban solution formulations
#1683Recombinant VWF formulations
#168417 alpha, 21-dihydroxypregnene esters as antiandrogenic agents
#1685Use of an amphoteric chelating agent for preventing contact allergies
#1686Adhesive patch comprising diclofenac sodium
#1687Compositions and methods for the treatment of intraocular neovascularization and/or leakage
#1688Antimicrobial compositions comprising glyceryl nitrates
#1689Injectable composition with aromatase inhibitor
#1690RESINIFERATOXIN SOLUTION
#1691COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLADDER CANCER
#1692Use of a cream that protects against the effects of aggressive chemical agents in contact with the skin
#1693Berberine formulations and uses thereof
#169417-Hydroxyprogesterone ester containing oral compositions and related methods
#1695Extruded extended release abuse deterrent pill
#1696BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#1697METHOD OF PREPARING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
#1698Formulation of diclofenac
#1699Formulation of diclofenac
#1700Risperidone or paliperidone implant formulation
#1701Sodium channel blocker delivery system with scleral lens
#1702Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
#1703Ionizable cationic lipid for RNA delivery
#1704Body fluid expanders comprising N-substituted aminosulfonic acid buffers
#1705Pharmaceutical Composition Comprising Abiraterone Acetate
#1706Formulations
#1707TREATMENT OF PREADOLESCENT MODERATE ACNE VULGARIS
#1708Diclofenac topical formulation
#1709DICLOFENAC TOPICAL FORMULATION
#1710N-methyl-N-acylglucamine-containing composition
#1711Stable Formulation of Insulin Glulisine
#1712Depot formulations of a local anesthetic and methods for preparation thereof
#1713Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar Solvent
#1714PARACETAMOL FOR PARENTERAL ADMINISTRATION
#1715Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
#1716APREPITANT ORAL LIQUID FORMULATIONS
#1717Nanoparticulate megestrol formulations
#1718Injectable Formulation
#1719Highly concentrated pharmaceutical formulations
#1720METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION
#1721Pharmaceutical composition containing crystalline sorafenib tosylate
#1722Therapeutic composition to treat lesions caused by Herpes Simplex Virus
#1723NANOPARTICLE COMPOSITIONS OF DIMETHYL FUMARATE
#1724RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules
#1725Liquid pharmaceutical formulations for injection comprising procaine and uses thereof
#1726Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof
#1727Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof
#1728Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof
#1729Lyophilized preparation of botulinum toxin
#1730METHODS FOR TREATMENT OF CERVICAL INSUFFICIENCY
#1731Material, method for preparing same, and uses thereof
#1732Nanoparticulate megestrol formulations
#1733Nanoparticulate megestrol formulations
#1734Kit-in-parts for cleaning and treating ears of companion animals
#1735Chewable gelled emulsions
#1736HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#1737ENHANCED IMMEDIATE RELEASE FORMULATIONS OF TOPIRAMATE
#1738PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#1739Sincalide Formulations
#1740Methods and Compositions for Deterring Abuse
#1741Diclofenac topical formulation
#1742Stabilized pharmaceutical dosage forms comprising atrasentan
#1743STABLE LIPOSOMES FOR DRUG DELIVERY
#1744Stabilized formulations of peptides and proteins protecting against non-enzymatic degradation
#1745STABILIZED GLUCAGON NANOEMULSIONS
#174617-hydroxyprogesterone ester containing oral compositions and related methods
#1747DERMAL DELIVERY DEVICE WITH IN SITU SEAL
#1748Formulations for the treatment of diabetes
#1749GLP-1 receptor stabilizers and modulators
#1750Cationic lipid having improved intracellular kinetics
#1751COMPOSITIONS AND METHODS FOR INJECTION OF A BIODEGRADABLE POLYMER-BASED DELIVERY SYSTEM
#1752FORMULATIONS FOR ENHANCED BIOAVAILABILITY OF ZANAMIVIR
#1753Cross-linked compositions
#1754Method for treating chronic wounds with an extracellular polymeric substance solvating system
#1755OLIGONUCLEOTIDE FORMULATION
#1756Nanoparticles and nanoparticle compositions
#1757LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
#1758PHARMACEUTICAL COMPOSITION COMPRISING A POORLY WATER-SOLUBLE ACTIVE INGREDIENT, A SURFACTANT AND A WATER-SOLUBLE POLYMER
#1759Drug formulations
#1760Compositions of a polyorthoester and an aprotic solvent
#1761Stabilisation of polypeptides
#1762Compositions of a polyorthoester and an aprotic solvent
#1763Compositions of a polyorthoester and an aprotic solvent
#176417-hydroxyprogesterone ester containing oral compositions and related methods
#1765Drug delivery system to increase bioavailability
#1766ANTIFUNGAL COMPOSITIONS FOR THE TREATMENT OF SECONDARY SKIN AND NAIL INFECTIONS
#1767Topical use of an antimicrobial formulation
#1768Topical compositions and methods of treatment of anorectal disorders
#1769Topical compositions and methods of treatment of topical disorders
#1770STABILIZED COMPOSITIONS AGAINST IONISING RADIATION
#1771Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
#1772Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
#1773Oral formulations and lipophilic salts of methylnaltrexone
#1774Biocompatible hydrogel treatments for retinal detachment
#1775Foamable carriers
#1776Otic composition for companion animals
#1777Antifungal compositions for the treatment of skin and nails
#1778Stable liquid formulation of etanercept
#1779STABILISED VACCINE COMPOSITION
#1780Stable formulations for parenteral injection of peptide drugs
#1781Stable formulations for parenteral injection of peptide drugs
#1782STABILIZED ANTHOCYANIN COMPOSITIONS
#1783Stable formulations for parenteral injection of peptide drugs
#1784Sodium channel blocker delivery system with scleral lens
#1785Allantoin-containing skin cream
#1786Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
#1787Sustained release formulations for delivery of proteins to the eye and methods of preparing same
#1788COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN
#1789Delivery of biologically-active agents using volatile, hydrophobic solvents
#1790Methods of manufacturing topical compositions and apparatus for the same
#1791Topical compositions
#1792IMMUNOSUPPRESSIVE MACROLIDE POWDER FOR ORAL SUSPENSION
#1793Chemical Permeation Enhancers Enhance Nerve Blockade by Toxins
#1794Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
#1795Transdermal hormone delivery system: compositions and methods
#1796Formulations of water-insoluble chemical compounds and methods of using a formulation of compound FL118 for cancer therapy
#1797Liquid stable virus vaccines
#1798Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same
#1799FORMULATIONS WITH REDUCED VISCOSITY
#1800Surface-modified heavy metal nanoparticles, compositions and uses thereof